Icore Global Medicines Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2013
About Icore Global Medicines
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Swapan Roy, Swarup Mitra, Kanika Maiti, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232WB2009PLC135575
- Company No.
135575
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2009
- Date of AGM
25 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Icore Global Medicines?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Roy  | Director | 02-Jun-2009 | Current |
| Swarup Mitra | Additional Director | 02-Feb-2010 | Current |
| Kanika Maiti | Director | 02-Jun-2009 | Current |
| Anukul Maiti | Director | 02-Jun-2009 | Current |
Financial Performance of Icore Global Medicines.
Enhance accessibility to Icore Global Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Icore Global Medicines?
Unlock access to Icore Global Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Icore Super Cement Private LimitedActive 16 years 23 daysSwapan Roy, Kanika Maiti and 1 more are mutual person
- Mega Mould India LimitedActive 19 years 5 months
Swapan Roy, Kanika Maiti and 1 more are mutual person
- Icore Jewellery & Gems Private LimitedActive 15 years 4 months
Swapan Roy, Kanika Maiti and 1 more are mutual person
- Promotech Infratech LimitedActive 12 years 3 months
Swapan Roy, Kanika Maiti and 1 more are mutual person
- Icore-E-Services LimitedActive 17 years 7 months
Swapan Roy, Kanika Maiti and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Icore Global Medicines?
Unlock and access historical data on people associated with Icore Global Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icore Global Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icore Global Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
